
Human Mitogen-activated protein kinase 1 138-146, KYIHSANVL
Description
About Human Mitogen-activated protein kinase 1 138-146, KYIHSANVL
The Human Mitogen-activated protein kinase 1 Peptide (IEDB: 191512) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Mitogen-activated protein kinase 1 Peptide, H-KYIHSANVL-OH (Uniprot: K7ELV1 aa: 138-146) from JPT is produced under strict quality control and quality management.
Human Mitogen-activated protein kinase 1 138-146, KYIHSANVL - Specifications
- Peptide sequence: H-KYIHSANVL-OH
- Amount: 10 mg (10 x 1 mg)
- Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
- Counterion: TFA
- Delivery Format: Freeze-dried in glass vial
- Application(s): T-cell Immunity
- Condition(s)/Topic(s): Melanoma
- Standard Delivery Time: approx. 3 weeks
JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!
Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!
References
References for Human Mitogen-activated protein kinase 1 138-146, KYIHSANVL
References:
Read References with JPT’s Antigen Peptides
Human Mitogen-activated protein kinase 1 138-146, KYIHSANVL has been described in:
Neoantigen-specific CD4<sup>+</sup> T cells in human melanoma have diverse differentiation states and correlate with CD8<sup>+</sup> T cell, macrophage, and B cell function., Cancer Cell, 2022 (PMID: 35413271)
Constitutive and inflammatory immunopeptidome of pancreatic β-cells., Diabetes, 2012 (PMID: 22872234)
SARS-CoV-2 genome-wide T cell epitope mapping reveals immunodominance and substantial CD8<sup>+</sup> T cell activation in COVID-19 patients., Sci Immunol, 2021 (PMID: 33853928)
Documentation
Documentation for Human Mitogen-activated protein kinase 1 138-146, KYIHSANVL
Properties
Properties of Human Mitogen-activated protein kinase 1 138-146, KYIHSANVL
Properties | Values |
---|---|
Application: | T-cell immunity |
Category: | Antigen Peptides |
Condition / Topic: | Melanoma |
Layout: | Freeze-dried in glass vial |
Organism: | Human |
Protein Name: | Mitogen-activated protein kinase 1 |
Purity: | Trial Grade: each peptide purified to > 90% (HPLC/MS) |
Quantification: | No, Yes |
Further Information to Human Mitogen-activated protein kinase 1 138-146, KYIHSANVL
Information | Values |
---|---|
Sequence: | H-KYIHSANVL-OH |
Specifications: | 9mer peptide as TFA salt |